Obstructive sleep apnea is a common breathing disorder in which airways repeatedly collapse during sleep, fragmenting sleep and reducing oxygen levels. While animal studies and clinical observations have suggested OSA might drive depression and anxiety, large prospective studies from representative populations have been lacking. This study used data from the Canadian Longitudinal Study on Aging (CLSA), a nationally representative cohort of middle-aged and older adults, to ask whether OSA risk genuinely predicts mental health decline over time.
The researchers analyzed 30,097 adults (median age 62 years) at baseline and followed 27,765 of them approximately 3 years later. They identified OSA risk using the validated STOP questionnaire (based on snoring, daytime sleepiness, witnessed apnea, and hypertension history), finding 23.5% at high risk at baseline. Mental health was assessed using a composite measure: depressive symptoms, psychological distress, diagnosed mental health conditions, or antidepressant use. About one-third of the sample met this composite outcome at each time point.
After adjusting for age, sex, BMI, and other confounders, high OSA risk was associated with 39–40% higher odds of poor mental health at both baseline and follow-up. A repeated-measures analysis (treating individuals as their own controls across time) found a 44% higher odds, suggesting the association is robust. Notably, the cross-sectional and longitudinal estimates were similar in magnitude, which is consistent but does not definitively prove OSA *causes* mental health decline—it could reflect bidirectional influence or shared underlying biology.
Key strengths include the large, nationally representative sample, prospective design, and validated instruments. Limitations are important: OSA was identified by questionnaire alone, not polysomnography (the gold standard); mental health was self-reported; residual confounding by unmeasured factors (e.g., pain, medication side effects) cannot be ruled out; and the 3-year follow-up, while adequate, cannot establish causality in the strictest sense. The authors did not report whether OSA treatment (e.g., CPAP) modified mental health outcomes, which would strengthen causal inference.
For longevity research, this study highlights an underappreciated pathway linking sleep disruption to neuropsychiatric aging. The magnitude of association (relative odds ~1.4) is clinically meaningful and comparable to other modifiable risk factors for mental health in aging. However, the cross-sectional nature of much of the analysis means we cannot yet say whether treating OSA will improve mental health outcomes—that remains an open question requiring randomized trials.
This work aligns with emerging evidence that sleep quality is a pillar of healthy aging and provides a rationale for screening and managing sleep disorders as part of integrated mental health and longevity strategies.
0 Comments
Log in to join the discussion.